Tranexamic-drl-logo (Tranexamic Drl Logo)
Tranexamic Acid Tablet
Product Images NDC 75907-309
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 75907-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tranexamic-labels-30 (Tranexamic Labels 30)
This is a description for Tranexamic Acid Tablets, USP 650 mg, manufactured for Appco Pharma LLC. The tablets are intended for adult use in managing menstrual symptoms, with a recommended dosage of two tablets three times daily during menstruation. It is important not to exceed six tablets in a 24-hour period, and the medication should be stored at 25°C with excursions permitted to 16-30°C. The tablets are dispensed in a tight, light-resistant container with a child-resistant closure. The product is distributed by Dr. Reddy's Laboratories in the USA.*
Tranexamicacid-spl-fig1 (Tranexamicacid Spl Fig1)
Tranexamicacid-spl-structure (Tranexamicacid Spl Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
